Our study on 192 Brazilian pancreatic cancer (PC) pts: 6.25% had pathogenic variants in predisposition genes (ATM, BRCA1/2, etc), 13% in others with limited PC links (CHEK2, etc.). 🌍 Ancestry or family history didn’t impact results.
https://t.co/ji3jLaW77m
BCS+RT=mastectomy+recon, but BCS+RT=improved psychosocial/sexual well-being. Important message for patients. @DrSummerHanson
Long-term Quality of Life After Breast Conservation vs Mastectomy and Reconstruction https://t.co/YCoiTcCuvy via @JAMASurgery part of @JAMANetwork
5G, inteligência artificial, cloud, IoT…novas tecnologias com potencial de melhorar o atendimento aos nossos pacientes. Obrigado @huaweibr pelo acolhimento! em São Paulo, Brazil https://t.co/NloWyTByoS
@RGuindalini é 1° autor de estudo na Scientific Reports demonstrando que o uso de testes de painel multigênico quase duplicou a identificação de variantes germinativas em genes de predisposição clinicamente acionáveis em pts com CA mama - https://t.co/jWNiOV01wY @dor_oncologia
Happy to share our data:
- TOP 3 mutated genes
BRCA1(27.4%),BRCA2(20.3%),TP53(10.5%)
-TP53 R337H
corresponded to 70% of all TP53 variants
detected in 1.6% of BC patients
strongly associated with risk of BC - OR = 17.4 (95% CI: 9.4–32.1; p < 0.0001)
https://t.co/jTiKkyd9rJ